MedTrace Logo

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

NCT00146666 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2009-12-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.

Conditions

  • Peripheral Arterial Disease
  • Intermittent Claudication

Interventions

DEVICE

Intermittent compression

Sponsors & Collaborators

  • FlowMedic

    lead INDUSTRY

Principal Investigators

  • Michael Koren, MD · Jacksonville Center For Clinical Research

  • Jeffrey M Martinez, MD · Peripheral Vascular Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00146666 on ClinicalTrials.gov